Insilico says its AI-designed lung drug lowered biological age markers in a 42-patient trial

Blood samples from a small lung-disease trial have been run through six independently built ageing clocks, and all six returned the same answer: the patients on the drug looked biologically younger than the patients on placebo. “More lifetimes than humanity lost in all the wars ever fought. If you manage to add 3 years to […] This story continues at The Next Web

Read it at The Next Web ↗

← Front page